HELP LINE:
844-775-2273
844-775-2273
KIMMTRAK CONNECT® is a support program available at no cost for adult patients receiving KIMMTRAK infusion for the treatment of metastatic uveal melanoma (mUM). Sponsored by Immunocore, the program matches patients and caregivers with a dedicated nurse case manager who is US-based and provides customized support—from financial assistance to scheduling appointments to educational support.
Please see the KIMMTRAK Patient Information and Important Safety Information below including BOXED WARNING for Cytokine Release Syndrome (CRS).
Your dedicated nurse case manager will help guide you through the services and support we offer.
We identify the options that are right for you. Once we understand your needs, we will help set you up with financial assistance.
Just tell us what you need, and we will try to help you manage your care. We may be able to assist you in locating affordable transportation to and from your treatment. We can also help coordinate infusion appointments once you and your physician choose a treatment location.
KIMMTRAK is a prescription medicine used to treat HLA-A*02:01-positive adults with uveal melanoma that cannot be removed by surgery or has spread.
What is the most important information I should know about KIMMTRAK?
KIMMTRAK can cause serious side effects that can be severe or life threatening and usually happen within the first three infusions, including:
Tell your healthcare provider right away if you get any of these symptoms. Your healthcare provider will check for these problems during treatment with KIMMTRAK. Your healthcare provider may temporarily stop or completely stop your treatment with KIMMTRAK if you have severe side effects.
See "KIMMTRAK can cause other serious side effects" for more information.
Before receiving KIMMTRAK, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
These are not all the side effects possible with KIMMTRAK.
Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 (1-800-332-1088).
Please read the accompanying Patient Information Leaflet before you receive KIMMTRAK and discuss any questions you have with your healthcare provider.
Please see KIMMTRAK Patient Information.
What is the most important information I should know about KIMMTRAK?
KIMMTRAK can cause serious side effects that can be severe or life threatening and usually happen within the first three infusions, including Cytokine Release Syndrome (CRS).
KIMMTRAK is a prescription medicine used to treat HLA-A*02:01-positive adults with uveal melanoma that cannot be removed by surgery or has spread.
What is the most important information I should know about KIMMTRAK?
KIMMTRAK can cause serious side effects that can be severe or life threatening and usually happen within the first three infusions, including Cytokine Release Syndrome (CRS).